Eli Lilly and Company (LLY) Stock Analysis

Last price: $1149.36as of 2026-09-04

Sector: Pharmaceuticals

GLP-1 drug pipeline (Mounjaro, Zepbound) and obesity market opportunity.

Dig deeper on LLY

DividendPrice Target & ForecastValuationFinancialsKey Statistics

Related content for LLY

In-Depth Report
Eli Lilly and Company (LLY) Full Analysis
16-section deep dive with valuation, technicals, and AI score
Blog
GLP-1 Obesity Drug Stocks
Compare
NVO vs LLY